DSM’s fibrous and soluble collagen have been implanted in more than 30 million patients over the past 30 years. Having partnerships with the leading global medical device companies, DSM manufactures collagen-based devices with a range of architecture, hydrophilicity, resorption time, and mechanical properties that address the widest array of regenerative medical applications.​

30M

Over 30 millions collagen
implants produced

100K

Over 100 thousand bone​
grafts per year

30

Over 30 years ​
of clinical use

Collagen functions

Markets served by this technology

  • Cardiovascular

    DSM Biomedical materials and technologies support cardiovascular applications, including neurologic and peripheral vascular. Learn more.

  • Dental

    DSM Biomedical technologies support tissue and bone growth for dental applications.

  • Orthopedics

    DSM Biomedical materials and technologies support orthopedic applications, including spine, trauma and sports medicine. Learn more.

  • Wound Management

    DSM Biomedical materials and technologies support wound management and wound applications. Learn more.

Collagen technology product sheet

Contact us to learn how collagen can add value to your products.

Read more

  • Our products

    DSM portfolio of innovative biomedical materials and process manufacturing technologies: Biomedical Polyethylenes, Biomedical polyurethanes, Collagen Technology, Device Development, and Extracellular Matrix (ECM) Technology. Learn more.

  • The markets we serve

    DSM Biomedical offers the broadest portfolio of biomedical materials and manufacturing across market applications, including orthopedics, ophthalmology, neurology, cardiology, diabetes, wound, and continence care.

Want to get in touch?

We'd love to hear from you!

This site uses cookies to store information on your computer.

Learn more